Cenexi

Cenexi company information, Employees & Contact Information

Explore related pages

Related company profiles:

Cenexi, a French Contract Development and Manufacturing Organization with its 1,500 employees and 200 million € of turnover, is experiencing a steady growth with its four manufacturing sites (Fontenay-sous-Bois, Osny and Hérouville-Saint-Clair in France, Braine-l'Alleud in Belgium) and one development center for New Product Introduction. Created in 2004, the Cenexi Group is positioned on the very active international market for medicinal products with a major therapeutic indication, drawing on its spirit of innovation and its extensive expertise, both in manufacturing and in product development The arrival of the new top management team induces a new dynamic into the company, in particular by strengthening its sterile expertise which represents 70% of our core business. Cenexi has the production capacities of many dosage forms with strong expertise in cytotoxic products (including hormonal).

Company Details

Employees
1.02K
Founded
-
Address
52 Rue Marcel Et Jacques Gaucher, Fontenay-Sous-Bois,94120,france
Phone
+33 1 43 94 88 00
Email
bo****@****olia.fr
Industry
Pharmaceutical Manufacturing
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing
In-Vitro Diagnostic Substance Manufacturing
Biological Product (except Diagnostic) Manufacturing
Website
cenexi.com
Keywords
to Pharma.
HQ
Fontenay-sous-bois
Looking for a particular Cenexi employee's phone or email?

Cenexi Questions

News

Gland Pharma Gets Yes Securities Add Upgrade; Sees U.S., Cenexi Business as Key Growth Drivers - NDTV Profit

Gland Pharma Gets Yes Securities Add Upgrade; Sees U.S., Cenexi Business as Key Growth Drivers NDTV Profit

Should you bet on Gland Pharma after Cenexi’s breakeven? - Value Research

Should you bet on Gland Pharma after Cenexi’s breakeven? Value Research

Gland Pharma Q1 profit jumps 50% on core growth, Cenexi turnaround - Business Standard

Gland Pharma Q1 profit jumps 50% on core growth, Cenexi turnaround Business Standard

Gland Pharma’s subsidiary Cenexi gets 11 observations from French regulator, operations unaffected - CNBC TV18

Gland Pharma’s subsidiary Cenexi gets 11 observations from French regulator, operations unaffected CNBC TV18

Cathay Capital Private Equity continues deploying its Midcap fund and supports the development of the Cenexi group - Cathay Capital

Cathay Capital Private Equity continues deploying its Midcap fund and supports the development of the Cenexi group Cathay Capital

India's Gland Pharma to buy Cenexi for $124 mln in Europe push - Reuters

India's Gland Pharma to buy Cenexi for $124 mln in Europe push Reuters

Gland Pharma's arm Cenexi gets 10 observations from French agency ANSM - Business Today

Gland Pharma's arm Cenexi gets 10 observations from French agency ANSM Business Today

Fosun Pharma Pours $220 Million Into France’s Cenexi - Caixin Global

Fosun Pharma Pours $220 Million Into France’s Cenexi Caixin Global

Cenexi appoints Jim McPherson as CEO - Indian Pharma Post

Cenexi appoints Jim McPherson as CEO Indian Pharma Post

Gland Pharma acquires French CDMO Cenexi for €120 million - The Economic Times

Gland Pharma acquires French CDMO Cenexi for €120 million The Economic Times

Cenexi turnaround brings Gland Pharma close to growth revival - Moneycontrol

Cenexi turnaround brings Gland Pharma close to growth revival Moneycontrol

Gland Pharma Reports 50% PAT Growth in Q1; Cenexi Achieves EBITDA Breakeven - scanx.trade

Gland Pharma Reports 50% PAT Growth in Q1; Cenexi Achieves EBITDA Breakeven scanx.trade

Gland Pharma’s Cenexi acquisition, new launches to help but execution is key | Stock Market News - Mint

Gland Pharma’s Cenexi acquisition, new launches to help but execution is key | Stock Market News Mint

Gland Pharma Q4 Results Preview: US Pick Up, New Launches, Cenexi Recovery To Offset Seasonal Weakness - NDTV Profit

Gland Pharma Q4 Results Preview: US Pick Up, New Launches, Cenexi Recovery To Offset Seasonal Weakness NDTV Profit

Gland Pharma to buy French pharma company Cenexi - Indian Pharma Post

Gland Pharma to buy French pharma company Cenexi Indian Pharma Post

Drug firm Gland Pharma to fully acquire Europe-based Cenexi Group - Business Standard

Drug firm Gland Pharma to fully acquire Europe-based Cenexi Group Business Standard

Gland Pharma signs non-binding pact to acquire Europe-based Cenexi for €120 million - CNBC TV18

Gland Pharma signs non-binding pact to acquire Europe-based Cenexi for €120 million CNBC TV18

Gland Pharma shares in focus after subsidiary Cenexi gets 11 observations from French regulator - The Economic Times

Gland Pharma shares in focus after subsidiary Cenexi gets 11 observations from French regulator The Economic Times

Gland Pharma Q4 Results Review: Core Weakness, Cenexi Hurdles Weigh On FY25 — Motilal Oswal Maintains Buy - NDTV Profit

Gland Pharma Q4 Results Review: Core Weakness, Cenexi Hurdles Weigh On FY25 — Motilal Oswal Maintains Buy NDTV Profit

Gland Pharma To Acquire France-Based Cenexi Group - NDTV Profit

Gland Pharma To Acquire France-Based Cenexi Group NDTV Profit

Gland Pharma posts 41% jump in quarterly revenue on Cenexi acquisition - Business Standard

Gland Pharma posts 41% jump in quarterly revenue on Cenexi acquisition Business Standard

Gland Pharma to acquire French firm Cenexi Group for Rs 1,000 crore - Business Standard

Gland Pharma to acquire French firm Cenexi Group for Rs 1,000 crore Business Standard

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant